
Japan’s No.1 in cardiovascular sales
We have the largest market share in the products for PCI (percutaneous coronary intervention), minimally invasive treatments for myocardial infarction and angina pectoris in Japan.
*(Source) WIN Partners

Financial summary.
WIN-Partners group aims for higher growth, by expanding sales network and customer base as well as expanding treatment areas and products.
NEWSNews Release
2025.03.10 | Notice Regarding the Status of Repurchase of Own Shares |
---|---|
2025.02.27 | Notice Regarding Repurchase of Own Shares |
2025.02.27 | Notice Regarding Revision of Dividend Projection |
2025.02.06 | 3Q presentation slides |
2025.02.06 | Consolidated Financial Results(Nine Months Ended December 31, 2024) |